PL2945965T3 - Peptyd - Google Patents

Peptyd

Info

Publication number: PL2945965T3
Authority: PL; Poland
Prior art keywords: peptide
Prior art date: 2013-01-15

Application number

PL14703176T

Other languages

English (en)

Inventor

David Wraith

Heather Streeter

Laurence ORDONEZ

Original Assignee

Apitope Technology (Bristol) Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-01-15

Filing date

2014-01-13

Publication date

2019-08-30

2014-01-13 Application filed by Apitope Technology (Bristol) Limited filed Critical Apitope Technology (Bristol) Limited

2019-08-30 Publication of PL2945965T3 publication Critical patent/PL2945965T3/pl

Links

108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Rehabilitation Therapy (AREA)
Mycology (AREA)
Microbiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Marine Sciences & Fisheries (AREA)

PL14703176T 2013-01-15 2014-01-13 Peptyd PL2945965T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB1300683.8A GB201300683D0 (en)	2013-01-15	2013-01-15	Peptide
PCT/IB2014/058234 WO2014111841A2 (en)	2013-01-15	2014-01-13	Peptide
EP14703176.9A EP2945965B8 (en)	2013-01-15	2014-01-13	Peptide

Publications (1)

Publication Number	Publication Date
PL2945965T3 true PL2945965T3 (pl)	2019-08-30

Family

ID=47757994

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL14703176T PL2945965T3 (pl)	2013-01-15	2014-01-13	Peptyd

Country Status (20)

Country	Link
US (4)	US20150352197A1 (pl)
EP (1)	EP2945965B8 (pl)
JP (2)	JP6407888B2 (pl)
KR (1)	KR102129763B1 (pl)
CN (1)	CN105102477B (pl)
AU (1)	AU2014206593B2 (pl)
CA (2)	CA2897894C (pl)
DK (1)	DK2945965T3 (pl)
ES (1)	ES2694660T3 (pl)
GB (1)	GB201300683D0 (pl)
HU (1)	HUE040547T2 (pl)
IL (1)	IL239870B (pl)
MX (1)	MX369413B (pl)
PL (1)	PL2945965T3 (pl)
PT (1)	PT2945965T (pl)
RU (1)	RU2667428C2 (pl)
SG (1)	SG11201505530XA (pl)
TR (1)	TR201815667T4 (pl)
WO (1)	WO2014111841A2 (pl)
ZA (1)	ZA201504986B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201300683D0 (en) *	2013-01-15	2013-02-27	Apitope Int Nv	Peptide
US20200087390A1 (en)	2016-12-21	2020-03-19	Amgen Inc.	Anti-tnf alpha antibody formulations
EP3668535A1 (en) *	2017-08-14	2020-06-24	Apitope Technology (Bristol) Limited	Method
EP4146190A2 (en)	2020-05-06	2023-03-15	Imcyse SA	Combination treatment for fumarate-related diseases
PH12023553212A1 (en)	2021-06-01	2024-02-19	Imcyse Sa	Improved methods of treatment using immunogenic peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6037135A (en) *	1992-08-07	2000-03-14	Epimmune Inc.	Methods for making HLA binding peptides and their uses
US9340577B2 (en) *	1992-08-07	2016-05-17	Epimmune Inc.	HLA binding motifs and peptides and their uses
WO1996032957A1 (en) *	1995-04-20	1996-10-24	Brigham & Women's Hospital	Modulation of cytokine patterns of human autoreactive t-cell clones
AU5671196A (en) *	1996-03-28	1997-10-17	Immulogic Pharmaceutical Corporation	Myelin oligodendrocyte glycoprotein peptides and uses thereof
CA2425648A1 (en) *	2000-10-19	2002-04-19	Epimmune Inc.	Hla class i and ii binding peptides and their uses
IL146016A0 (en) *	2001-10-17	2002-07-25	Yeda Res & Dev	Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis
US20060229233A1 (en) *	2004-06-25	2006-10-12	Id Biomedical Corporation	Compositions and methods for treating neurological disorders
US8188218B2 (en) *	2006-10-27	2012-05-29	University Of Kansas	Bi-functional peptides for multiple sclerosis treatment and diagnosis
EP2621522A2 (en) *	2010-09-27	2013-08-07	China Agricultural University	Combined antigen and dna vaccine for preventing and treating autoimmune diseases
GB201300683D0 (en) *	2013-01-15	2013-02-27	Apitope Int Nv	Peptide

2013
- 2013-01-15 GB GBGB1300683.8A patent/GB201300683D0/en not_active Ceased
2014
- 2014-01-13 MX MX2015009086A patent/MX369413B/es active IP Right Grant
- 2014-01-13 TR TR2018/15667T patent/TR201815667T4/tr unknown
- 2014-01-13 CN CN201480009124.4A patent/CN105102477B/zh active Active
- 2014-01-13 US US14/760,492 patent/US20150352197A1/en not_active Abandoned
- 2014-01-13 EP EP14703176.9A patent/EP2945965B8/en active Active
- 2014-01-13 PL PL14703176T patent/PL2945965T3/pl unknown
- 2014-01-13 PT PT14703176T patent/PT2945965T/pt unknown
- 2014-01-13 ES ES14703176.9T patent/ES2694660T3/es active Active
- 2014-01-13 KR KR1020157020498A patent/KR102129763B1/ko not_active Expired - Fee Related
- 2014-01-13 JP JP2015552189A patent/JP6407888B2/ja not_active Expired - Fee Related
- 2014-01-13 CA CA2897894A patent/CA2897894C/en active Active
- 2014-01-13 WO PCT/IB2014/058234 patent/WO2014111841A2/en not_active Ceased
- 2014-01-13 HU HUE14703176A patent/HUE040547T2/hu unknown
- 2014-01-13 RU RU2015134357A patent/RU2667428C2/ru active
- 2014-01-13 AU AU2014206593A patent/AU2014206593B2/en not_active Ceased
- 2014-01-13 SG SG11201505530XA patent/SG11201505530XA/en unknown
- 2014-01-13 DK DK14703176.9T patent/DK2945965T3/en active
- 2014-01-13 CA CA3154542A patent/CA3154542A1/en active Pending
2015
- 2015-07-09 IL IL239870A patent/IL239870B/en active IP Right Grant
- 2015-07-10 ZA ZA2015/04986A patent/ZA201504986B/en unknown
2018
- 2018-07-27 JP JP2018141119A patent/JP2018193390A/ja not_active Withdrawn
2019
- 2019-03-26 US US16/365,365 patent/US20190275126A1/en not_active Abandoned
2021
- 2021-03-01 US US17/188,318 patent/US20220016226A1/en not_active Abandoned
2023
- 2023-08-11 US US18/448,678 patent/US20240148843A1/en active Pending

Also Published As

Publication number	Publication date
JP6407888B2 (ja)	2018-10-17
TR201815667T4 (tr)	2018-11-21
WO2014111841A2 (en)	2014-07-24
JP2018193390A (ja)	2018-12-06
MX2015009086A (es)	2016-02-16
WO2014111841A3 (en)	2014-10-30
EP2945965B1 (en)	2018-07-25
IL239870B (en)	2018-10-31
KR20150107766A (ko)	2015-09-23
US20240148843A1 (en)	2024-05-09
US20220016226A1 (en)	2022-01-20
HK1211595A1 (en)	2016-05-27
ZA201504986B (en)	2019-04-24
US20190275126A1 (en)	2019-09-12
MX369413B (es)	2019-11-07
GB201300683D0 (en)	2013-02-27
DK2945965T3 (en)	2018-11-19
JP2016504412A (ja)	2016-02-12
CA3154542A1 (en)	2014-07-24
PT2945965T (pt)	2018-11-14
ES2694660T3 (es)	2018-12-26
KR102129763B1 (ko)	2020-07-03
AU2014206593A1 (en)	2015-07-23
RU2015134357A (ru)	2017-02-22
CN105102477A (zh)	2015-11-25
CA2897894C (en)	2022-06-21
CA2897894A1 (en)	2014-07-24
SG11201505530XA (en)	2015-08-28
IL239870A0 (en)	2015-08-31
US20150352197A1 (en)	2015-12-10
HUE040547T2 (hu)	2019-03-28
RU2667428C2 (ru)	2018-09-19
CN105102477B (zh)	2019-03-19
EP2945965B8 (en)	2018-09-05
AU2014206593B2 (en)	2017-09-07
EP2945965A2 (en)	2015-11-25

Publication	Publication Date	Title
IL242005B (en)	2019-05-30	A peptide compound
GB201311475D0 (en)	2013-08-14	Polypeptides
SMT202000250T1 (it)	2020-07-08	Peptide antimicrobico
GB201314411D0 (en)	2013-09-25	Peptide conjugates
ZA201600729B (en)	2019-12-18	Peptides
GB201308057D0 (en)	2013-06-12	Protein
ZA201504986B (en)	2019-04-24	Peptide
PL3061771T3 (pl)	2020-10-19	Nowy peptyd o czterech połączonych epitopach dla ctl
ZA201504987B (en)	2017-11-29	Peptide
GB201309421D0 (en)	2013-07-10	Polypeptides
GB201315130D0 (en)	2013-10-09	Peptides
PL2983690T3 (pl)	2019-09-30	Peptydy pochodzące od neuropeptydu Y
GB201401955D0 (en)	2014-03-19	Protein
PL3080276T3 (pl)	2018-08-31	Polipeptydy toksyczne dla owadów
GB201316660D0 (en)	2013-11-06	Peptides
GB201300381D0 (en)	2013-02-20	Peptides
GB201305465D0 (en)	2013-05-08	Novel peptides
GB201302030D0 (en)	2013-03-20	Protein
GB201302031D0 (en)	2013-03-20	Protein
GB201322749D0 (en)	2014-02-05	Cyclic peptide
GB201317839D0 (en)	2013-11-20	Anti-Microbial peptides
GB201318182D0 (en)	2013-11-27	Inhibitor peptides
GB201318451D0 (en)	2013-12-04	W/C Sani-vent
GB201308193D0 (en)	2013-06-12	Peptide product
GB201308191D0 (en)	2013-06-12	Peptide product